Cargando…

Structural and functional abnormalities in iron-depleted heart

Iron deficiency (ID) is a common and ominous comorbidity in heart failure (HF) and predicts worse outcomes, independently of the presence of anaemia. Accumulated data from animal models of systemic ID suggest that ID is associated with several functional and structural abnormalities of the heart. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobak, Kamil A, Radwańska, Malwina, Dzięgała, Magdalena, Kasztura, Monika, Josiak, Krystian, Banasiak, Waldemar, Ponikowski, Piotr, Jankowska, Ewa A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394598/ https://www.ncbi.nlm.nih.gov/pubmed/30284070 http://dx.doi.org/10.1007/s10741-018-9738-4

Ejemplares similares

Iron Depletion Affects Genes Encoding Mitochondrial Electron Transport Chain and Genes of NonOxidative Metabolism, Pyruvate Kinase and Lactate Dehydrogenase, in Primary Human Cardiac Myocytes Cultured upon Mechanical Stretch
por: Dziegala, Magdalena, et al.
Publicado: (2018)

Iron deficiency as energetic insult to skeletal muscle in chronic diseases
por: Dziegala, Magdalena, et al.
Publicado: (2018)

Iron limitation promotes the atrophy of skeletal myocytes, whereas iron supplementation prevents this process in the hypoxic conditions
por: Kobak, Kamil, et al.
Publicado: (2018)

Skeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormones
por: Josiak, Krystian, et al.
Publicado: (2014)

Depleted iron stores are associated with inspiratory muscle weakness independently of skeletal muscle mass in men with systolic chronic heart failure
por: Tkaczyszyn, Michał, et al.
Publicado: (2018)

Evaluation of Skeletal Muscle Function and Effects of Early Rehabilitation during Acute Heart Failure: Rationale and Study Design
por: Węgrzynowska-Teodorczyk, Kinga, et al.
Publicado: (2018)

Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners
por: Drozd, Marcin, et al.
Publicado: (2016)

Primary Human Cardiomyocytes and Cardiofibroblasts Treated with Sera from Myocarditis Patients Exhibit an Increased Iron Demand and Complex Changes in the Gene Expression
por: Kobak, Kamil A., et al.
Publicado: (2021)

Iron Status and Short-Term Recovery after Non-Severe Acute Myocarditis: A Prospective Observational Study
por: Franczuk, Paweł, et al.
Publicado: (2023)

Iron status, catabolic/anabolic balance, and skeletal muscle performance in men with heart failure with reduced ejection fraction
por: Tkaczyszyn, Michał, et al.
Publicado: (2021)

Iron Deficiency in Heart Failure: A Korea-Oriented Review
por: Jankowska, Ewa A., et al.
Publicado: (2023)

Health locus of control and the sense of self-efficacy in patients with systolic heart failure: a pilot study
por: Rydlewska, Agnieszka, et al.
Publicado: (2013)

Monitoring of iron status in patients with heart failure
por: Jankowska, Ewa A, et al.
Publicado: (2019)

Iron Deficiency and Deranged Myocardial Energetics in Heart Failure
por: Tkaczyszyn, Michał, et al.
Publicado: (2022)

Iron deficiency as an emerging therapeutic target in patients stabilized after an episode of acute heart failure
por: Tkaczyszyn, Michał, et al.
Publicado: (2021)

Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives
por: Jankowska, Ewa A., et al.
Publicado: (2013)

Percutaneous reduction of mitral valve regurgitation using the MitraClip system – immediate and 90-day follow-up of 3 cases
por: Kübler, Piotr, et al.
Publicado: (2013)

Deranged iron status in psoriasis: the impact of low body mass
por: Ponikowska, Malgorzata, et al.
Publicado: (2015)

Patterns of dyspnoea onset in patients with acute heart failure: clinical and prognostic implications
por: Sokolska, Justyna Maria, et al.
Publicado: (2018)

Induction of Day-Time Periodic Breathing is Associated With Augmented Reflex Response From Peripheral Chemoreceptors in Male Patients With Systolic Heart Failure
por: Niewinski, Piotr, et al.
Publicado: (2022)

Distinct clinical phenotypes of congestion in acute heart failure: characteristics, treatment response, and outcomes
por: Sokolska, Justyna Maria, et al.
Publicado: (2020)

Acute hyperoxia reveals tonic influence of peripheral chemoreceptors on systemic vascular resistance in heart failure patients
por: Tubek, Stanislaw, et al.
Publicado: (2021)

Rationale and design of the AMULET study: A new Model of telemedical care in patients with heart failure
por: Krzesiński, Paweł, et al.
Publicado: (2021)

Hemosiderin Accumulation in Liver Decreases Iron Availability in Tachycardia-Induced Porcine Congestive Heart Failure Model
por: Kasztura, Monika, et al.
Publicado: (2022)

Nurse‐led ambulatory care supported by non‐invasive haemodynamic assessment after acute heart failure decompensation
por: Krzesiński, Paweł, et al.
Publicado: (2021)

Effects of an outpatient intervention comprising nurse‐led non‐invasive assessments, telemedicine support and remote cardiologists' decisions in patients with heart failure (AMULET study): a randomised controlled trial
por: Krzesiński, Paweł, et al.
Publicado: (2021)

Drug therapy in elderly heart failure patients
por: Jankowska, Ewa A, et al.
Publicado: (2019)

Comparison of left ventricular longitudinal systolic function parameters in the prediction of adverse outcome in heart failure with preserved ejection fraction
por: Gozdzik, Anna, et al.
Publicado: (2021)

Identification of Chronic Heart Failure Patients with a High 12-Month Mortality Risk Using Biomarkers Including Plasma C-Terminal Pro-Endothelin-1
por: Jankowska, Ewa A., et al.
Publicado: (2011)

Role of skeletal muscle perfusion and insulin resistance in the effect of dietary sodium on heart function in overweight
por: Keske, Michelle A., et al.
Publicado: (2021)

Differences in the Biomarker Profile of De Novo Acute Heart Failure versus Decompensation of Chronic Heart Failure
por: Nawrocka-Millward, Sylwia, et al.
Publicado: (2021)

Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost‐effectiveness analysis utilising AFFIRM‐AHF
por: McEwan, Phil, et al.
Publicado: (2021)

Decreased Serum Level of Interleukin-22 Correlates with Hepcidin in Patients with Hidradenitis Suppurativa
por: PONIKOWSKA, Malgorzata, et al.
Publicado: (2021)

Safety and efficacy of His bundle pacing validated by extracardiac vagal nerve stimulation (HIS-STORY)
por: Josiak, Krystian, et al.
Publicado: (2022)

Pathophysiology and Treatment Opportunities of Iron Deficiency in Heart Failure: Is There a Need for Further Trials?
por: Tkaczyszyn, Michał, et al.
Publicado: (2023)

Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiency
por: Butler, Javed, et al.
Publicado: (2022)

Patients with heart failure and concomitant chronic obstructive pulmonary disease participating in the Heart Failure Pilot Survey (ESC-HF Pilot) – Polish population
por: Straburzyńska-Migaj, Ewa, et al.
Publicado: (2015)

Differences between intravenous iron products: focus on treatment of iron deficiency in chronic heart failure patients
por: Martin‐Malo, Alejandro, et al.
Publicado: (2019)

Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup Analysis
por: Filippatos, Gerasimos, et al.
Publicado: (2023)

Search for the Function of NWC, Third Gene Within RAG Locus: Generation and Characterization of NWC-Deficient Mice
por: Kasztura, Monika, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cr3jtgpto9q52k0sji9srq470e